ArticleScientific reports2026
Independent inner cell mass and trophectoderm morphology as non-invasive predictors of embryo euploidy in IVF.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic analysis of biopsy-related droplets in patients undergoing PGT-A and its potential application.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the independent correlation between inner cell mass (ICM) and trophectoderm (TE) grading with preimplantation genetic testing for aneuploidy (PGT-A) outcomes in embryos biopsied on Day 5 or Day 6 to determine whether morphology-based selection can serve as an alternative to PGT-A. A retrospective analysis of 1,292 embryos from patients undergoing IVF at a single academic center was conducted between October 2019 and March 2023. Blastocysts were graded using Society for Assisted Reproductive Technology (SART) morphology criteria, and biopsy results were categorized as euploid, aneuploid, mosaic, inconclusive, or low DNA. Maternal age (24-45 years) was analyzed both by SART age groups (< 35, 35-37, 38-40, 41-42, > 42) and in a multivariable logistic regression (euploid vs aneuploid) adjusting for age, biopsy day (Day 5 vs Day 6), inner cell mass (ICM), and trophectoderm (TE). Embryos with mosaic, inconclusive, or low-DNA results were excluded from inferential analyses. Statistical analysis was performed using the chi-square test (p < 0.05). Of the 1,292 embryos, 632 (48.9%) were euploid, 508 (39.3%) aneuploid, and 152 (11.8%) mosaic or inconclusive. Good ICM embryos had significantly higher euploidy rates than aneuploidy on both biopsy days (p < 0.001), while poor ICM embryos had higher aneuploidy rates (p < 0.001). Similarly, good TE embryos were more likely to be euploid than poor TE embryos (p < 0.001). Day 5 embryos had significantly higher euploidy rates than Day 6 embryos across all grading categories (p < 0.05). However, no statistical difference was found between Day 6 good ICM embryos and Day 5 fair ICM embryos (p = 0.1335), while Day 6 good TE embryos had higher euploidy than Day 5 fair TE embryos (p < 0.01). Euploidy declined stepwise across SART age groups. In the adjusted model, each additional year of maternal age after 35 lowered the odds of euploidy by ~ 6%. Both ICM and TE grades predict embryo euploidy, supporting the use of morphological assessment to optimize embryo selection and potentially reduce reliance on PGT-A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.